Expired Canadian patentCanada
6,8-dimercarptooctanoic acid derivatives substituted in 6-s and/or 8-s by the radical (3-methylthiopropanoyl) and pharmaceutical compositions used to treat cancerous tumors
CA 2264985 C · Owner: Galderma Research & Development, S.N.C. · Inventors: Gore, Jacques; Quash, Gerard Anthony; Fournet, Guy
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordRead the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 31, 1999 and granted December 9, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 31, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 31, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 31, 1999
GrantedDecember 9, 2003
Term endedMarch 31, 2019
Patent numberCA 2264985 C
Classification (IPC)C07C323/52 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.